Fig. 13

Meta-analysis of adverse prognosis: high-titer versus low-titer subgroup of the serum anti-PLA2R antibody -positive group
Meta-analysis of adverse prognosis: high-titer versus low-titer subgroup of the serum anti-PLA2R antibody -positive group